Success Stories: Despite an RFE and a Long Wait, NIW Approval was Achieved for an Editor the Biochemistry Field from Russia

 

Client’s Testimonial:

“Thank you very much for confirming the receipt of the approval notice. Loved interacting with the team. Straightforward, timely, and helpful. :)”

---

On January 25^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Editor in the Field of Biochemistry (Approval Notice).

---

General Field: Biochemistry

Position at the Time of Case Filing: Editor

Country of Origin: Russia

State of Residence at the Time of Filing: New York

Approval Notice Date: January 25^th, 2023

Processing Time: 13 months, 18 days

---

Case Summary:

When our client, at that time an editor in the field of biochemistry from Russia, approached the North America Immigration Law Group to help him file his NIW petition, we ensured to go through his credentials carefully and accumulate the relevant data for his NIW petition packet. Thus, we added the following:

• We discovered that as an expert in the field of biochemistry, our client’s focus is on developing tools for genomic alignment, quantification of single-cell RNA-sequencing (RNA-seq) data, and analysis of allele-specific RNA-seq datasets to improve the early detection of disease in personalized molecular medicine.
• Other professionals in the field have confirmed that our client’s record of successful research has well-placed him to continue advancing the proposed endeavor. We submitted four letters of recommendation in his petition packet. One of them had the following statement:

“[Client’s] project has inherent value to the United States, as it uncovers new avenues for disease screening that are minimally invasive, rapid, and inexpensive. The Office of the Surgeon General of the United States reports that, by expanding screening and preventive services for cardiovascular disease alone, tens of thousands of lives will be saved each year. Given his contributions to early disease detection through extracellular RNA research, he has proven himself to be an asset to the public health goals of the United States.”

• Therefore, we were certain that our client’s research has great importance because it addresses the genetic mechanisms of fundamental biological functions and molecular processes, with the particular goal of guiding the development of precision medicine-based therapeutics and diagnostic tools and techniques.
• We have also emphasized that his research has resulted in 4 peer-reviewed journal articles, altogether acquiring a total of 215 citations thereby confirming that his research is important and has critical implications for disease treatment and prevention in the United States and worldwide.
• Also, we noted that he had completed at least 12 reviews to date for authoritative journals, it is apparent that he is seen as very knowledgeable in the field and an expert in topics related to his proposed endeavor.

Unfortunately, our client received a Request for Additional Evidence (RFE) while filing for his NIW case. However, our diligent team worked tirelessly to gather solid evidence and promptly responded to the case with the required relevant information. We are delighted to announce that our client received his NIW approval successfully from USCIS. We wish to extend our warmest congratulations to him and thank him for preferring our services and entrusting us with his case.

---